Impaired Cardiometabolic Responses to Glucagon-Like Peptide 1 in Obesity and Type 2 Diabetes Mellitus

Glucagon-Like Peptide 1 (GLP-1) has insulin-like effects on myocardial glucose uptake which may contribute to its beneficial effects in the setting of myocardial ischemia. Whether these effects are different in the setting of obesity or type 2 diabetes (T2DM) requires investigation. We examined the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moberly, Steven P, Mather, Kieren J, Berwick, Zachary C, Owen, Meredith K, Goodwill, Adam G, Casalini, Eli D, Hutchins, Gary D, Green, Mark A, Ng, Yen, Considine, Robert V, Perry, Kevin M, Chisholm, Robin L, Tune, Johnathan D
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3731771/
https://ncbi.nlm.nih.gov/pubmed/23764734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00395-013-0365-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados